Early Postoperative Hyperamylasemia is a Critical Predictor of Pancreatic Fistula and Mortality, Suggests Study
A recent retrospective study published in the Indian Journal of Surgery in August 2026 warns that early postoperative hyperamylasemia (POH) is not just a routine response to surgical trauma but a critical predictor of severe complications. This enzyme spike correlates with a more than doubled postoperative pancreatic fistula rate (38.4% vs 17.9%) and a striking fourfold increase in 30-day mortality (8.2% vs 1.9%).
Traditionally, an elevation in postoperative serum amylase has been proposed as an early marker of pancreatic injury after pancreaticoduodenectomy (PD); however, its clinical relevance and relationship with major complications defined by the International Study Group of Pancreatic Surgery (ISGPS) remain uncertain. To address this clinical gap, lead author Mert Ozdemir and his co-investigators conducted a study to evaluate the association between early POH and clinical outcomes following PD.
Therefore, the retrospective, single-center study analyzed a total of 195 patients who underwent PD between 2017 and 2024, ultimately including 179 subjects in the final analysis after applying strict predefined exclusion criteria. The research team defined POH as a serum amylase level exceeding 100 U/L on postoperative days one and two, subsequently analyzing its specific relationship to POPF, delayed gastric emptying (DGE), postpancreatectomy hemorrhage (PPH), and 30-day mortality rates.
Key Clinical Findings of the Study Includes:
- High Prevalence: The study reported that POH occurred in 40.8% of patients (73 out of 179) on the first two postoperative days.
- Increased Fistula Risk: The study showed that overall POPF occurred in 38.4% of patients with POH, which was significantly higher than the 17.9% seen in the non-POH group (p=0.002).
- Non-Significant Clinically Relevant Fistula: The study noted that although clinically relevant grade B–C POPF was more frequent in POH patients (19.2% versus 10.4%), this difference did not reach statistical significance (p=0.095).
- Structural and Inflammatory Links: The study associated POH with smaller pancreatic duct diameters and elevated levels of C-reactive protein (CRP), a key inflammatory marker.
- Elevated Short-Term Mortality: The study identified a significantly higher 30-day mortality rate of 8.2% in the POH group compared to just 1.9% in patients with normal amylase levels (p=0.044), whereas DGE and PPH rates remained statistically similar.
The results suggest that early POH, which occurred in 40.8% of the cohort, serves as a powerful indicator of pancreatic remnant vulnerability, as evidenced by its strong correlation with an increased incidence of POPF (38.4%) and a heightened systemic inflammatory response. Consequently, this biochemical marker is a critical early warning sign that is directly associated with a significantly elevated 30-day mortality rate of 8.2% following pancreatic resection.
Given the increased vulnerability of the pancreatic remnant in these patients, clinicians may consider utilizing early serum amylase monitoring as a valuable tool to risk-stratify patients and implement proactive management strategies to mitigate potential complications.
Although the research is limited by its retrospective, single-center design, it underscores a vital need for larger, prospective trials to further validate these findings and establish standardized clinical protocols for high-risk patients.
Reference
Ozdemir, M., Gumusoglu, A. Y., Kabuli, H. A., Kesgin, Y. M., Cayirci, C. E., & Surek, A. (2026). Postoperative Serum Amylase Elevation and Its Impact on Complications After Pancreaticoduodenectomy. Indian Journal of Surgery. Published online: 24 August 2026.
